엑스탄트 (XTNT)

Market Highlights: Xtant Medical Holdings Inc (XTNT) Ends on a Low Note at 0.72 – DWinneX - The Dwinnex

The Dwinnex

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200 Day Moving Average of $0.00 - MarketBeat

MarketBeat

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200-Day Moving Average of $0.00 - Defense World

Defense World

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 - Yahoo Finance

Yahoo Finance

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 - Yahoo Finance

Yahoo Finance

Xtant Medical Enters Wound Care Market With Two Products - https://ryortho.com/

https://ryortho.com/

Xtant Medical Enters Wound Care Market With Two Products - https://ryortho.com/

https://ryortho.com/

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - Defense World

Defense World

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - Defense World

Defense World

Xtant Medical shares target raised by BTIG on strong Q1 results - Investing.com

Investing.com

Xtant Medical shares target raised by BTIG on strong Q1 results - Investing.com

Investing.com

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - MarketBeat

MarketBeat

Earnings call: Xtant Medical projects strong growth and increased revenue in 2024 - Investing.com Australia

Investing.com Australia

Earnings call: Xtant Medical projects strong growth and increased revenue in 2024 By Investing.com - Investing.com UK

Investing.com UK

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Earnings call: Xtant Medical projects strong growth and increased revenue in 2024 - Investing.com South Africa

Investing.com South Africa

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving Average of $0.00 - Defense World

Defense World

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance - Yahoo Finance

Yahoo Finance

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00 - MarketBeat

MarketBeat

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - Yahoo Finance

Yahoo Finance

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - Yahoo Finance

Yahoo Finance

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds

GlobeNewswire Inc.

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds - OrthoSpineNews

OrthoSpineNews

Xtant Medical Holdings Inc Stock Quote | Stock Price for XTNT | FinancialContent Business Page - Financial Content

Financial Content

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

GlobeNewswire Inc.

Xtant Medical Holdings Inc (XTNT) Reports Record Revenue in 2023, Outpacing Analyst Estimates - Yahoo Finance

Yahoo Finance

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

GlobeNewswire Inc.

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

GlobeNewswire Inc.

Xtant Acquires NanOss Production Operations From RTI Surgical - Contract Pharma

Contract Pharma

Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical - OrthoSpineNews

OrthoSpineNews

Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - OrthoSpineNews

OrthoSpineNews

Xtant Buys Surgalign’s Spine and Biologics Business for $5M - https://ryortho.com/

https://ryortho.com/

Xtant Medical completes $15m private placement - Medical Device Network

Medical Device Network

Xtant Medical closes $15M private placement - Mass Device

Mass Device

Surgalign Declares Bankruptcy - https://ryortho.com/

https://ryortho.com/

Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale ... - GlobeNewswire

GlobeNewswire

Xtant Medical completes acquisition of Surgalign product lines - Medical Device Network

Medical Device Network

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million - GlobeNewswire

GlobeNewswire

Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment - OrthoSpineNews

OrthoSpineNews

XTNT: Does Xtant Medical Holdings Deserve a Spot in Your Portfolio? - StockNews.com

StockNews.com

Xtant Medical Hldgs Stock (AMEX:XTNT), Quotes and News Summary - Benzinga

Benzinga

Xtant Medical Announces Closing of Debt Restructuring - OrthoSpineNews

OrthoSpineNews

Xtant Medical Launches Three Novel Spinal Implants - https://ryortho.com/

https://ryortho.com/

8 Top Gainers In Pharma Sector (NOVN, TNXP, KOD...) - RTTNews

RTTNews

curasan Inc. announces Orthopedic Private Label Distribution Agreement - OrthoSpineNews

OrthoSpineNews

Xtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C™ Cervical Cage - OrthoSpineNews

OrthoSpineNews

Vivex Biomedical Signs Deals with Arthrex and Xtant Medical - https://ryortho.com/

https://ryortho.com/

XTANT, SeaSpine and RTI Surgical: Blending Biologics and Hardware - https://ryortho.com/

https://ryortho.com/

Xtant Medical Announces First Surgical Use of OsteoSelect® PLUS DBM Putty - OrthoSpineNews

OrthoSpineNews